PureTech Health (UK) Today

PRTC Stock   128.80  0.80  0.63%   

Performance

Mild

 
Weak
 
Strong

Odds Of Distress

Small

 
High
 
Low
PureTech Health is selling for under 128.80 as of the 14th of February 2026; that is 0.63 percent increase since the beginning of the trading day. The stock's lowest day price was 127.2. PureTech Health has about a 27 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 16th of November 2025 and ending today, the 14th of February 2026. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
Category
Healthcare
Classification
Health Care
PureTech Health is entity of United Kingdom. It is traded as Stock on LSE exchange. The company has 241.68 M outstanding shares. More on PureTech Health plc

Moving against PureTech Stock

  0.53GSC GS Chain PLCPairCorr
  0.420NPL Christian Dior SEPairCorr

PureTech Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. PureTech Health's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding PureTech Health or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CoFounder PresidentEric Elenko
Thematic Ideas
(View all Themes)
Business ConcentrationLife Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Management, IT, Health Care, Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Computing (View all Sectors)
PureTech Health's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to PureTech Health's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
PureTech Health can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand PureTech Health's financial leverage. It provides some insight into what part of PureTech Health's total assets is financed by creditors.
Liquidity
PureTech Health cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. PureTech Health plc has accumulated 159.14 M in total debt. Debt can assist PureTech Health until it has trouble settling it off, either with new capital or with free cash flow. So, PureTech Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like PureTech Health plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for PureTech to invest in growth at high rates of return. When we think about PureTech Health's use of debt, we should always consider it together with cash and equity.

Depreciation

3.94 Million
PureTech Health plc (PRTC) is traded on London Exchange in UK and employs 56 people. PureTech Health is listed under Life Sciences Tools & Services category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 309.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PureTech Health's market, we take the total number of its shares issued and multiply it by PureTech Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. PureTech Health plc operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 241.68 M outstanding shares. PureTech Health generates negative cash flow from operations
Check PureTech Health Probability Of Bankruptcy
Ownership Allocation
PureTech Health owns a total of 241.68 Million outstanding shares. The majority of PureTech Health plc outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in PureTech Health plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in PureTech Health. Please pay attention to any change in the institutional holdings of PureTech Health plc as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check PureTech Ownership Details

PureTech Health Historical Income Statement

At this time, PureTech Health's Minority Interest is comparatively stable compared to the past year. Net Interest Income is likely to gain to about 15.3 M in 2026, whereas Selling General Administrative is likely to drop slightly above 27.2 M in 2026. View More Fundamentals

PureTech Stock Against Markets

PureTech Stock Analysis Notes

About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.13. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PureTech Health plc had not issued any dividends in recent years. To find out more about PureTech Health plc contact the company at 617 482 2333 or learn more at https://www.puretechhealth.com.

PureTech Health Quarterly Total Revenue

1.85 Million

PureTech Health plc Investment Alerts

PureTech Health generates negative cash flow from operations
About 72.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: PureTech Health Stock Crosses Below 50 Day Moving Average - Heres Why - MarketBeat

PureTech Health Thematic Classifications

In addition to having PureTech Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Health Management Idea
Health Management
Healthcare providers, hospitals
IT Idea
IT
Information technology and IT services

PureTech Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 309.36 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PureTech Health's market, we take the total number of its shares issued and multiply it by PureTech Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

PureTech Profitablity

PureTech Health's profitability indicators refer to fundamental financial ratios that showcase PureTech Health's ability to generate income relative to its revenue or operating costs. If, let's say, PureTech Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, PureTech Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of PureTech Health's profitability requires more research than a typical breakdown of PureTech Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 7.93 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of (25.9) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $25.9.

Management Efficiency

PureTech Health plc has return on total asset (ROA) of (0.1295) % which means that it has lost $0.1295 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0944 %, meaning that it generated $0.0944 on every $100 dollars invested by stockholders. PureTech Health's management efficiency ratios could be used to measure how well PureTech Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, PureTech Health's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 146.2 M in 2026, whereas Other Assets are likely to drop 1,092 in 2026.
Leadership effectiveness at PureTech Health plc is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Operating Margin
(25.90)
Profit Margin
7.9296
Beta
0.716
Return On Assets
(0.13)
Return On Equity
0.0944

Technical Drivers

As of the 14th of February 2026, PureTech Health holds the Semi Deviation of 1.34, risk adjusted performance of 0.0361, and Coefficient Of Variation of 2568.47. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PureTech Health, as well as the relationship between them. Please check PureTech Health plc maximum drawdown, potential upside, and the relationship between the treynor ratio and value at risk to decide if PureTech Health plc is priced some-what accurately, providing market reflects its current price of 128.8 per share.

PureTech Health plc Price Movement Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. PureTech Health plc Tanh Of Price Series is a hyperbolic price transformation function.

PureTech Health Outstanding Bonds

PureTech Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. PureTech Health plc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most PureTech bonds can be classified according to their maturity, which is the date when PureTech Health plc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

PureTech Health Predictive Daily Indicators

PureTech Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PureTech Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

PureTech Health Forecast Models

PureTech Health's time-series forecasting models are one of many PureTech Health's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary PureTech Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Be your own money manager

Our tools can tell you how much better you can do entering a position in PureTech Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Crypto Correlations Now

   

Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module

PureTech Health Corporate Management

Elected by the shareholders, the PureTech Health's board of directors comprises two types of representatives: PureTech Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PureTech. The board's role is to monitor PureTech Health's management team and ensure that shareholders' interests are well served. PureTech Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PureTech Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Frank SalisburySenior StrategyProfile
Michael ChenChief SeaportProfile
Anita JDSenior PropertyProfile
Lauren MBAChief OfficerProfile
RDN MSChief OfficerProfile

Additional Tools for PureTech Stock Analysis

When running PureTech Health's price analysis, check to measure PureTech Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PureTech Health is operating at the current time. Most of PureTech Health's value examination focuses on studying past and present price action to predict the probability of PureTech Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PureTech Health's price. Additionally, you may evaluate how the addition of PureTech Health to your portfolios can decrease your overall portfolio volatility.